# AbbVie Inc. (ABBV) — Q4-2025 Earnings Results

**Report date:** 2026-02-04 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2025

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Down 3.79%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.71 | N/A | +2.03% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a cautiously optimistic outlook despite current market challenges. They emphasized the importance of their pipeline and ongoing product performance.

**Key quotes:**

> Management highlighted ongoing strength in key product lines.

> They acknowledged challenges in the market but expressed confidence in long-term strategies.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 3.79%, likely due to the lack of revenue details and no guidance for the future. Investors may be concerned about the company's outlook amid market challenges.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2025_